The Cooper Companies, Inc. COO
Rating
Rating Factors
Company Overview
The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. The company operates primarily through two business units: CooperVision and CooperSurgical. CooperVision develops and manufactures contact lenses, including toric, multifocal, spherical, and myopia management lenses, while CooperSurgical provides fertility, reproductive health, and gynecological medical devices and services. The company operates within the broader healthcare, medical technology, and specialty medical products industries, with revenue driven largely by recurring demand for disposable contact lenses and fertility-related products and procedures.
The company serves eye care professionals, fertility clinics, hospitals, surgical centers, and healthcare providers across developed and emerging markets. A key strategic advantage is its diversified exposure to both vision care and women’s health, including strong positions in specialty contact lenses and fertility treatment technologies. Founded in 1958, Cooper evolved from a diversified healthcare holding company into a focused medical technology enterprise through acquisitions, divestitures, and expansion into global healthcare markets. The company significantly expanded its women’s health business through acquisitions including Origio, LifeGlobal, and Generate Life Sciences, while continuing to build scale in contact lenses through manufacturing and product innovation.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $51.01
- Current
- $56.57
- High
- $89.83
Valuation
Dividends and Shares
Corporate Info
Suite 500
San Ramon, CA 94583